Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast

Lin H Soe, Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA Abstract: Ospemifene is a selective estrogen receptor modulator (SERM), or estrogen receptor...

Full description

Bibliographic Details
Main Authors: Soe LH, Wurz GT, Kao CJ, DeGregorio MW
Format: Article
Language:English
Published: Dove Medical Press 2013-09-01
Series:International Journal of Women's Health
Online Access:http://www.dovepress.com/ospemifene-for-the-treatment-of-dyspareunia-associated-with-vulvar-and-a14481